SEATTLE (AP) — SEATTLE (AP) — Perspective Therapeutics, Inc. (CATX) on Tuesday reported a loss of $15.1 million in its third quarter.

On a per-share basis, the Seattle-based company said it had a loss of 21 cents.

The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 21 cents per share.

The isotope-based medical products maker posted revenue of $369,000 in the period.

Perspective Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.75, more than quadrupling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CATX at https://www.zacks.com/ap/CATX